1. Home
  2. CRBU vs MGYR Comparison

CRBU vs MGYR Comparison

Compare CRBU & MGYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRBU
  • MGYR
  • Stock Information
  • Founded
  • CRBU 2011
  • MGYR 1922
  • Country
  • CRBU United States
  • MGYR United States
  • Employees
  • CRBU N/A
  • MGYR N/A
  • Industry
  • CRBU Medicinal Chemicals and Botanical Products
  • MGYR Savings Institutions
  • Sector
  • CRBU Health Care
  • MGYR Finance
  • Exchange
  • CRBU Nasdaq
  • MGYR Nasdaq
  • Market Cap
  • CRBU 93.0M
  • MGYR 91.4M
  • IPO Year
  • CRBU 2021
  • MGYR 2006
  • Fundamental
  • Price
  • CRBU $1.06
  • MGYR $15.90
  • Analyst Decision
  • CRBU Strong Buy
  • MGYR
  • Analyst Count
  • CRBU 4
  • MGYR 0
  • Target Price
  • CRBU $8.50
  • MGYR N/A
  • AVG Volume (30 Days)
  • CRBU 943.1K
  • MGYR 8.3K
  • Earning Date
  • CRBU 05-08-2025
  • MGYR 07-24-2025
  • Dividend Yield
  • CRBU N/A
  • MGYR 1.64%
  • EPS Growth
  • CRBU N/A
  • MGYR 19.38
  • EPS
  • CRBU N/A
  • MGYR 1.43
  • Revenue
  • CRBU $9,918,000.00
  • MGYR $34,067,000.00
  • Revenue This Year
  • CRBU N/A
  • MGYR N/A
  • Revenue Next Year
  • CRBU $161.81
  • MGYR N/A
  • P/E Ratio
  • CRBU N/A
  • MGYR $11.12
  • Revenue Growth
  • CRBU N/A
  • MGYR 12.12
  • 52 Week Low
  • CRBU $0.66
  • MGYR $10.66
  • 52 Week High
  • CRBU $3.00
  • MGYR $16.00
  • Technical
  • Relative Strength Index (RSI)
  • CRBU 56.92
  • MGYR 71.22
  • Support Level
  • CRBU $0.98
  • MGYR $15.22
  • Resistance Level
  • CRBU $1.21
  • MGYR $15.51
  • Average True Range (ATR)
  • CRBU 0.10
  • MGYR 0.32
  • MACD
  • CRBU 0.02
  • MGYR 0.07
  • Stochastic Oscillator
  • CRBU 65.99
  • MGYR 93.75

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.

About MGYR Magyar Bancorp Inc.

Magyar Bancorp Inc is a mid-tier stock holding company. The Company offers a full array of commercial and retail financial services, including the taking of time, savings and demand deposits; the making of commercial, consumer and home equity loans; and the provision of other financial services. The business consists of getting retail deposits from the general public in the areas surrounding the main office in New Brunswick, New Jersey and branch offices located in Middlesex and Somerset Counties, New Jersey, and investing those deposits, together with funds generated from operations and wholesale funding, in residential mortgage loans, home equity loans, home equity lines of credit, commercial real estate loans, commercial business loans, Small Business Administration loans.

Share on Social Networks: